MOG Antibody-Associated Disease in the Setting of Metastatic Melanoma Complicated by Immune Checkpoint Inhibitor Use.

Stephanie B Syc-MazurekHannah Zhao-FlemingYong Guo Nanthaya Tisavipat John J Chen Anastasia ZekeridouIoannis KournoutasJacob J OrmeMatthew S BlockClaudia F LucchinettiRafid Mustafa Eoin Patrick Flanagan

Published in: Neurology(R) neuroimmunology & neuroinflammation (2024)

This case revealed a presentation of MOGAD concurrent with melanoma without tumor MOG immunostaining. We highlight tocilizumab as a dual-purpose treatment of MOGAD and the neurologic immune-related adverse effect of ICI.

Keyphrases

rheumatoid arthritis
single cell
emergency department
rheumatoid arthritis patients
locally advanced
electronic health record